Tenders Are Invited For Production Of A Clinical Lot Of The Primvac Vaccine Candidate In E. Coli For The Benefit Of The Inserm U1134

Contract Notice: Production Of A Clinical Lot Of The Primvac Vaccine Candidate In E. Coli For The Benefit Of The Inserm U1134 Pharmacy Services Short Description: Inserm U1134 Aims To Continue The Development Of The Primvac Vaccine Against Gestational Malaria. The Purpose Of This Market Is To Produce A Clinical Batch Of Antigen ("Drug Substance") In The Recombinant System E. Coli Shuffle And The Final Vaccine In Bottles ("Drug Product"). Deadline For Submission: 20230309 17:00 Type Of Buyer: Body Governed By Public Law Type Of Contract: Services Type Of Procedure: Open Procedure Regulation: European Union, With Participation By Gpa Countries Type Of Bid: Submission For All Lots Award Criteria: The Most Economic Tender [Disclaimer: The Above Text Is Machine Translated. For Accurate Information Kindly Refer The Original Document.] Tender Link : Https://Ted.Europa.Eu/Udl?Uri=Ted:Notice:081937-2023:Data:En:Html